Cingulate CING
NASDAQ CING
$5.55 +0.22 (+4.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cingulate (CING) Enterprise Value (2021 - 2026)

Cingulate's (CING) quarterly Enterprise Value came in at -$11.0 million in Q4 2025, up 10.3% YoY from -$9.9 million in Q4 2024, and down 79.56% on a QoQ basis from -$6.1 million in Q3 2025.

Cingulate (CING) Enterprise Value (2021 - 2026) Analysis & Trends

Cingulate (CING) has 5 years of Enterprise Value data on file, last reported at -$11.0 million in Q4 2025.

  • Quarterly Enterprise Value rose 10.3% year-over-year to -$11.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$11.0 million (up 10.3% YoY) and the FY2025 annual result came in at -$11.0 million, up 10.3% from the prior year.
  • Enterprise Value slipped to -$11.0 million in Q4 2025, from -$6.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$52416.0 in Q4 2023 to a low of -$16.5 million in Q4 2021.
  • A 5-year average of -$7.1 million and a median of -$7.8 million in 2025 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2023 — Enterprise Value soared 99.02% — and 2024, when it slumped 23196.93%.
  • Tracing CING's Enterprise Value over 5 years: stood at -$16.5 million in 2021, then soared by 67.53% to -$5.4 million in 2022, then soared by 99.02% to -$52416.0 in 2023, then tumbled by 23196.93% to -$12.2 million in 2024, then grew by 10.3% to -$11.0 million in 2025.
  • The last three Enterprise Value figures came in at -$11.0 million (Q4 2025), -$6.1 million (Q3 2025), and -$9.5 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 2.12 Bn
10 Cingulate 72.85 Mn 72.85 Mn - -28.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -28.40 Mn
Dec 31, 2025 -10.95 Mn
Sep 30, 2025 -6.10 Mn
Mar 31, 2025 -9.50 Mn
Dec 31, 2024 -12.21 Mn
Sep 30, 2024 -10.04 Mn
Jun 30, 2024 -380,928.00
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 -52,416.00
Sep 30, 2023 -1.99 Mn
Jun 30, 2023 -349,831.00
Mar 31, 2023 -1.74 Mn
Dec 31, 2022 -5.36 Mn
Sep 30, 2022 -9.80 Mn
Jun 30, 2022 -15.71 Mn
Mar 31, 2022 -12.62 Mn
Dec 31, 2021 -16.49 Mn